Schleibner S, Welter H, Abendroth D, Illner W D, Hillebrand G, Albert E, Schneeberger H, Wiesel M, Land W
Department of Surgery, Klinikum Grosshadern, University of Munich.
Clin Transpl. 1988:107-14.
The use of different immunosuppressive protocols (high-dose/low-dose CsA) has little effect on first cadaveric transplants in nonsensitized patients. However, low-dose CsA induction treatment reduces early nephrotoxic crises. There is a clear benefit of quadruple drug induction treatment for retransplants and sensitized transplant candidates. Steroid-free immunosuppressive therapy can be applied to a majority of long-term patients.